AU634987B2 - A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins - Google Patents

A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins Download PDF

Info

Publication number
AU634987B2
AU634987B2 AU44951/89A AU4495189A AU634987B2 AU 634987 B2 AU634987 B2 AU 634987B2 AU 44951/89 A AU44951/89 A AU 44951/89A AU 4495189 A AU4495189 A AU 4495189A AU 634987 B2 AU634987 B2 AU 634987B2
Authority
AU
Australia
Prior art keywords
plant
document
napus
albumin
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU44951/89A
Other versions
AU4495189A (en
Inventor
Luiz Barreto De Castro
Ann De Clercq
Eugen Gander
Enno Krebbers
Marc Van Montagu
Joel Vanderkerckhove
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience NV
Empresa Brasileira de Pesquisa Agropecuaria EMBRAPA
Original Assignee
Plant Genetic Systems NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88402650A external-priority patent/EP0318341B1/en
Application filed by Plant Genetic Systems NV filed Critical Plant Genetic Systems NV
Publication of AU4495189A publication Critical patent/AU4495189A/en
Application granted granted Critical
Publication of AU634987B2 publication Critical patent/AU634987B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
    • C12N15/8253Methionine or cysteine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
    • C12N15/8254Tryptophan or lysine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

OPI
PCT
DATE 01/05/90 APPLN. ID 44951 89 AOJP DATE 07/06/90 PCT NUMBER PCT/EP89/01229 INTERNATIONAL r. A. uL.n A vi u Iv jL. Y (PCT) (51) International Patent Classification 5 (11) International Publication Number: WO 90/04032 C12N 15/82, 15/29, 5/14 Al AO1H 5/00 (43) International Publication Date: 19 April 1990 (19.04.90) (21)International Application Number: PCT/EP89/01229 (72) Inventors; and Inventors/Applicants (for US only) DE CLERCQ, Ann (22) International Filing Date: 13 October 1989 (13.10.89) [BE/BE]; Berkenlaan 130, B-8730 Harelbeke (BE).
KREBBERS, Enno [US/US]; 1724 Glenview, Alhambra, CA 91803 VANDERKERCKHOVE, Joel [BE/ Priority data: BE]; Rode Beukendreef 27, B-8021 Loppem (BE).
88402611.3 14 October 1988 (14.10.88) EP BARRETO DE CASTRO, Luiz [BR/BR]; Shin QI 14 (34) Countries for which the regional Conjunto 05, Casa 17, 71500-Brasilia, DF GANor international application DER, Eugen [CH/BR]; SQS 409 Bloco B, Entrada B, was filed: AT et al. Apt. 202, 70258-Brasilia, DF VAN MONTAGU, 88402650.1 20 October 1988 (20.10.88) EP Marc [BE/BE]; De Strassartstraat 120, B-1050 Brussels (34) Countries for which the regional (BE).
or international application wasfiled: AT et al. (74) Agents: PLASSERAUD, Yves et al.; S.C. Ernest Gutmann-Yves Plasseraud, 67, bd. Haussmann, F-75008 Paris (FR).
(71) Applicants (for all designated States except US): PLANT GENETIC SYSTEMS N.V. [BE/BE]; Kolonel Bourgstraat 106, B-1040 Brussels EMPRESA BRASI- (81) Designated States: AU, JP, US.
LEIRA DE PESQUISA AGROPECUARIA (EMBRA- PA) [BR/BR]; Parque Rural, 70770-Brasilia, DF Published With international search report.
Before the expiration of the time limit for amending the claims and to be republished in the event of the receipt of amendments.
6349 (54) Title: A PROCESS FOR THE PRODUCTION OF TRANSGENIC PLANTS WITH INCREASED NUTRITIONAL VA- LUE VIA THE EXPRESSION OF MODIFIED 2S STORAGE ALBUMINS (57) Abstract The invention pertains to a process for producing transgenic plants with increased nutritional value. It comprises: cultivating plants obtained from regenerated plant cells or from seeds of plants obtained from said regenerated plant cells over one or several generations, whose genetic patrimony, replicable with said plants, comprises a precursor-coding nucleic acid sequence encoding the precursor of a 2S albumin storage protein and placed under the control of a promoter capable of directing gene expression in plants, said precursor-coding nucleic acid being modified in a nonessential region of its relevant sequence which encodes the mature 2S albumin or a subunit thereof with a nucleic acid insert in appropriate reading frame relationship with the surrounding part of said relevant sequence, said insert including a determined segment encoding an heterologous determined polypeptide containing appropriate aminoacid such as lysine and/or methionine and/or threonine and/or phenylalanine and/or trytophane and/or leucine and/or valine and/or isoleucine.
WO 90/04032 PCT/EP89/01229 1 A process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins This invention relates to a process for the production of plants with increased content of appropriate aminoacids having high nutritional properties through the modification of plant genes encoding plant storage proteins, more particularly the 2S albumins.
More particularly, the invention aims at providing genetically modified plant DNA and plant live material including said genetically modified DPA replicable with the cells of said plant material, which genetically modified plant DNA contains sequences encoding for a polypeptide containing said appropriate aminoacids which expression is under the control of a suitable plant promoter.
A further object of the invention is to take advantage of the capacity of 2S albumins to be produced in large amounts in plants.
A further object of the invention is to take advantage of a hypervariable region of the 2S albumins, which supplementation with a number of said appropriate aminoacid codons in said hypervariable region of the gene encoding said 2S albumins, do not disturb the correct expression, processing and transport of said produced modified storage proteins in the protein bodies of the plants.
Animals and men obtain directly or indirectly their essential aminoacids by eatin, plants. These essential rPio7 hqn aminoacids include lysine, -tephane, threonine, methi ine, phenylalanine, leucine, valine and isoleucine. For the easiness of the language these aminoacids are called "apprepriate aminoacids". Rather recently, agricultural sciLa tists concerned with the world's hungry problem, concentrated their work on developing plants with high nutritional yield. These new varieties, obtained through breeding in j WO 90/04032 PCT/EP89/01229 2 the mcst cases, were richer in carbohydrates but usually poorer in essential proteins than the wild type varieties from which they were derived. Currently, increasing recognition of the role of plants in supplying essential aminoacids to the animal world had led to emphasis on the development of new food plants having a better aminoacid content.
Classical breeding however has limitations for achieving this goal. Molecular genetics, on the contrary, offers a possibility to overcome these difficulties. Reference is made to the European patent application 80208418 and the communication of Brown et al., 1986, in which a gene encoding a corn seed storage protein, (the so called zeins) is modified by the addition of sequences encoding lysine codons.
Seed storage proteins represent up to 90% of total seed protein in seeds of miny plants. They are used as a source of nutrition for v'ung seedlings in the period immediately after germination. The genes encoding them are strictly regulated, being expressed in a highly tissue specific and stage specific fashion (Walling et al., 1986; Higgins, 1984). Thus they are expressed almost exclusively in developing seed, and different classes of seed storage proteins may be expressed at different stages in the development of the seed. They are generally restricted in their intercellular location, being stored in membrane bound organelles called protein bodies or protein storage vacuoles. These organelles provide a protease-free environment, and often also contain protease inhibitors. A related group of proteins, the vegetative storage proteins, have similar aminoacid compositions and are also stored in specialized vacuoles, but are found in leaves instead of in seeds (Staswick, 1988). These proteins are degraded upon flowering, and are thought to serve as a nutritive source for developing seeds.
WO 90/04032 PCT/EP89/01229 3 The expression of foreign genes in plants is well established (De Blaere et al., 1987). In several cases seed storage protein genes have been transferred to other plants. In most of these cases it was shown that within its new environment the transferred seed storage protein gene is expressed in a tissue specific and developmentally regulated manner (Beachy et al., 1985; Sengupta-Gopalan et al., 1985; Marris et al., 1988; Ellis et al., 1988; Higgins et al., 1986, Okamuro et al., 1986). It has also been shown in at least two cases that foreign seed storage proteins are located in the protein bodies of the host plant (Greenwood and Chrispeels, 1985; Hoffman et al., 1987). It has further been shown that stable and functional messenger RNA's can be obtained if a cDNA, rather than a complete gene including introns, is used as the basis for the chimeric gene (Chee et al., 1986).
Storage proteins are generally classified on the basis of solubility and size (more specifically sedimentation rate, for instance as defined by Svedberg (in Stryer, L., Biochemistry, 2nd ed., W.H. Freeman, New York: page 599)). A particular class of seed storage proteins has been studied, the 2S seed storage proteins, which are water soluble albumins. They represent a significant proportion of the seed storage proteins in many plants (Youle and Huang, 1981) (Table I) and their small size and consequently simpler structure makes them an attractive target for modification (see also patent application EP 87 402 348.4). Several 2S storage proteins have been characterized at either the protein, cDNA or genomic clone levels (Crouch et al., 1983; Sharief and Li, 1982; Ampe et al., 1986; Altenbach et al., 1987; Ericacn et al., 1986; De Castro et al., 1987; Scofield and Crouch, 1987; Josefsson et al., 1987; EP 87.4023484, Krebbers et al., 1988). 2S albumins are formed in the cell from two subunits of 6-9 and 3-4 kilodaltons (kd) respectively, which are linked by disulfide bridges.
4 The work in the references above showed that 2S albumins are synthesized as complex prepropeptides whose organization is shared between the 2S albumins of many different species and are shown diagrammatically for three of these species in figure 1. Several complete sequences are shown in figure 2.
As to Fig. 2 relative to protein sequences of 2S albumins, the following observations are made. For B. -apusD f.
excelsia, and A. thaliana both the protein and DNA sequences have been determined, for e. communis only the protein sequence is available napus from Crouch et al., 1983 and Ericson et al., 1986; f. excelsia from Ampe et al., 1986, De Castro et al., 1987 and Altenbach et al., 1987, E. communis from Sharief and Li, 1982). Boxes indicate homologies, and raised dots the position of the cysteines.
Comparison of the protein sequences at the beginning of the precursor with standard consensus sequences for signal peptides reveals that the precursor has not one but two segments at the amino terminus which are not present in the mature protein, the first of which is a signal sequence (Perlman and Halvorson, 1983) and the second of which has been designated as the amino terminal processed fragment (the so-called ATPF). Signal sequences serve to ensure the cotranslational transport of the nascent polypeptide across the membrane of the endoplasmic reticulum (Blobel, 1980), and are found in many types of proteins, including all seed storage proteins examined to date (Herman et al., 1986). This is crucial for the appropriate compartmentalization of the protein. The protein is further folded in such a way that correct disulfide bridges are formed. This process is probably localized at the luminal site of the endoplasmatic reticulum membrane, where the enzyme disulfide isomerase is localized (Roden et al., 1982; Bergman and Kuehl, 1979). After translocation across the endoplasmic reticulum membrane it is thought that most storage proteins are transported via said WO 90/04032 PCT/EP89/01229 endoplasmic reticulum to the Golgi bodies, and from the latter in small membrane bound vesicles ("dense vesicles") to the protein bodies (Chrispeels, 1983; Craig and Goodchild, 1984; Lord, 1985). That the signal peptide is removed cotranslationally implies that the signals directing the further transport of seed storage proteins to the protein bodies must reside in the remainder of the protein sequence present. Zeins and perhaps some other prolaminins deviate from this pathway; indeed the protein bodies ae formed by budding directly off of the endoplasmic reticulum (Larkins and Hurkman, 1978). As already of record, 2S albumins contain sequences at the amino end of the precursor other than the signal sequence which are not present in he mature polypeptide. This is not general to all storage proteins. This amino terminal processed fragment is labeled ATPF in figure 1.
In addition, as shown in figure 1, several aminoacids located between the small and large subunits in the precursor are removed (labeled IPF in the figure, which stands for internal processed fragment), Furthermore, several residues are removed from the carboxyl end of the precursor (labeled CTPF in the figure which stands for carboxyl terminal processed fragment). The cellular location of these latter processing steps is uncertain, but is most likely the protein bodies (Chrispeels et al., 1983; Lord, 1985). As a result of these processing steps the small subunit and the large subunit remain. These are linked by disulfide bridges, as discussed below.
When the protein sequences of 2S albumins of different plants are compared strong structural similarities are observed. This is more particularly illustrated by figure 2 which provides the aminoacid sequences of the small subunit and large subunit respectively of representative 2S storage seed albumin proteins of different plants, R. comm. Ricinus communis t\ I i I j: 1 t 1 II WO 90/04032 PCT/EP89/01229 6 A. thali.: Arabidopsis thaliana B. napus Brassica napus B. excel.: Bertholletia excelsia (Brazil nut) It must be noted that in Fig. 2: the aminoacid sequences of said subunits extend on several lines; the cysteine groups of the aminoacid sequences of the exemplified storage proteins and identical aminoacids in several of said proteins have been brought into vertical alignment; the hyphen signs which appear in some of these sequences represent absent aminoacids, in other words direct linkages between the closest aminoacids which surrounded them; the aminoacid sequences which in the different proteins are conserved are framed.
It will be observed that all the sequences contain eight cysteine residues (the first and second in the small subunit, the remainder in the large subunit) which could participate in disulfide bridges as diagrammatically shown in Fig. 3, which represents a hypothetical model (for the purpose of the present discussion) rather than a representation of the true structure of the 2S albumin of Arabidopsis thaliana.
Said hypothetical model has been inspired by the disulfide bridge mediated loop-formation nimal albumins, such as serum albumins (Brown, 1976), alpha-fetoprotein (Jagodzinski et al., 1987; Morinaga et al., 1983) and the vitamine D binding protein where analogous constant C-C doublets and C-X-C triplets were observed (Yang et al., 1985).
As can be seen on Fig. 2, the regions which are intercalated between the first and second cysteines, between the fifth and sixth cysteines, and between the seventh and eight cysteines of the mature protein show a substantial degree of conservation or similarity. It would thus seem that these E regions are in some way essential for the proper folding A I r i i WO 90/04032 PCT/EP89/01229 7 and/or stability of the protein when synthesized in the plants. An exception to this conservation consist in the distance between the sixth and seventh cysteine residues. This suggests that these arrangements are structurally important, but that some variation is permissible in the large subunit between said sixth and seventh cysteines where little conservation of aminoacids is observed.
An analogous suggestion has been made by Slightom and Chee (1987), where the viciline type seed storage proteins from peas were compared. These authors indeed suggest that aminoacid replacement mutations designed to increase the number of sulphur containing aminoacids should be placed in regions which show little or no conservation of aminoacid sequences.
The authors however conclude that the proof that such modifications can be tolerated will need to be tested is. the seeds of transgenic plants. Moreover, the teaching provided in their paper on the properties of the through deletion modified storage protein concerns only the influence on expression levels and not on processing of said storage proteins.
An embodiment of this invention is the demonstration that a well chosen region of the 2S albumin allows variation without altering the properties and correct processing of said modified storage protein in plant cells of transgenic plants.
This region (diagrammatically shown in Fig. 3 by an enlarged hatched portion) will in the examples hereafter referred to be termed as the "hypervariable region". Fig. 3 also shows the respective positions of the other parts of the precursor sequence, including the "IPF" section separating the small subunit and large subunit of the precursor, as well as the number of aminoacids (aa) in substantially conserved portions of the protein subunits cysteine residues. The processing cleavage sites (as determined by Krebbers et al., 1988) are shown by symbols.
WO 90/04032 PCT/EP89/01229 8 The seeds of many plants contain albumins of approximately the same size as the storage proteins discussed above.
However, for ease of language, this document will use the term "2S albumins" to refer to seed proteins whose genes encode a peptide precursor with the general organization shown in figure 1 and which are processed to a final form consisting of two subunits linked by disulfide bridges. The process of the invention for producing plants with an increased content of appropriate aminoacids comprises cultivating plants obtained from regenerated plant cells or from seeds of plants obtained from said regenerated plant cells over one or several generations, wherein the genetic patrimony or information of said plant cells, replicable within said plants, includes a nucleic acid sequence, placed under the control of a plant promoter, which can be transcribed into t.le mRNA enccding at least part of the precursor of a 2S albumin including the signal peptide of said plant, said nucleic acid being hereafter referred to as the "precursor encoding nucleic acid" wherein said nucleic acid contains a nucleotide sequence (hereafter termed the "relevant sequence") which relevant sequence comprises a nonessential region modified by a heterologous nucleic acid insert forming an open reading frame in reading phase with the non modified parts surrounding said insert in said relevant sequence.
wherein said insert includes a nucleotide segment encoding a polypeptide containing appropriate ami- 0 noacids.
It will be appreciated that under the above mentioned conditions each and every cell of the cultivated plant will include the modified nucleic acid. Yet the above defined recombinant er hybrid sequence will be expressed at high levels constitutively or only or mostly in certain organs of WO 90/04032 PCT/EP89/01229 9 the cultivated plants dependent on which plant promoter has been chosen to conduct its expression. In the case of seed-specific promoters the hybrid storage protein will be produced mostly in the seeds.
It will be understood that the "heterologous nucleic acid insert" defined above consists of an insert which contains nucleotide sequences which at least in part, may be foreign to the natural nucleic acid encoding the precursor of the 2S albumins of the plant cells concerned and encode the appropriate aminoacids. Most generally the segment encoding polypeptide containing said appropriate aminoacids will itself be foreign to the natural nucleic acid encoding the precursor of said storage protein. Nonetheless, the term "heterologous nucleic acid insert" does also extend to an insert containing a segment as above-defined normally present in the genetic patrimony or information of said plant cells, the "heterologous" character of said insert then addressing to the different genetic environment which surrounds said insert.
In the preceding definition of the process according to the invention the so-called "nonessential region" of the relevant sequence of said nucleic acid encoding the precursor, consists of a region whose nucleotide sequence can be modified either by insertion into it of the above defined insert or by replacement of at least part of said nonessential region by said insert, yet without disturbing the stability and correct processing of said hybrid storage protein as well as its transport into the above-said protein bodies.
Sequences consisting of said insert or replacement and representing the coding region for a polypeptide containing appropriate aminoacids can either be put in as synthetic oligomers or as restriction fragments isolated from other genes, as thought by Brown, 1986. The total length of the hybrid storage protein may be longer or shorter than the total length of the non-modified 2S albumin.
WO 90/04032 PCT/EP89/01229 With respect to the choice of the region to be modified, the present invention is clearly distinguishable from other work which has been done in this field. Reference is made to DD-A-240911 patent fros the Akademie der Wissenschaften der DDR where legumin genes from Vicia faba, (glutine and prolamine) were modified in vitro with sequences encoding methionine. As place of insert a natural occurring PstI site has been chosen. At the EMBO workshop "Plant storage protein genes", (Breisach, FRG, September 1986) the authors presented their wark and informed the audience that plant transformation experiments were just started with the modified gene.
No further results have yet been published.
Reference is also made to patent application WO-A-87/07299 and corresponding publication of Radke et al., S 1988. These papers describe the modification of the napin gene, which encodes the 2S albumin of Srassica napus, by a nucleotide sequence encoding nine aminoacid residues including 5 consecutive methionines. The region of modification is a naturally occurring SstI site within the region encoding the mature protein. Such a modification would result in a insertion directly adjacent to a cysteine residue and moreover in a region between two cysteines, namely the 4th and the 5th cysteines of the mature protein which correspond with the 2nd and 3rd cysteines of the large subunit, whose length is strongly conserved (see above). We believe such a modification is likely to disrupt a normal folding and stability of the 2S albumin (see also EP 87 402 348.4). Moreover, above cited references provide no evidence that the desired modified 2S albumin was successfully synthesized, correctly processed or soirectly targeted.
In the present invention the precursor-coding nucleic acid referred to above may of course originate from the same plant species as that which is cultivated for the purpose of the invention. It may however originate from another plant species, in line with the teachings of Beachey et al., 1985 and Okamuro et al., 1986 already of record.
11 In a similar manner the plant promoter may originate from the same plant species or from another, subject in the last instance to the capability of the host plant's polymerases to recognize it. It may act constitutively or in a tissue-specific manner, such as, but not limited to, seed-specific promoters.
Regions such as the ones at the end of the small subunit, at the beginning or end of the large subunit, show differences of such a magnitude that they car: be held as presumably having no substantial impact on the final properties of the protein. The extreme carboxyl terminus of the small subunits and the amino terminus of the large subunit may, however, be involved in the processing of the internal processed fragment. A region which does not seem essential, consists of the middle position of the region located in the large subunit, between the sixth and the seventh cysteine of the native protein, preferably not Immediately adjacent to said cysteines and more preferably located at least 3 aminoacids from said cysteines, Thus in addition to the absence of similarity at the level of the aminoacid residues, there appears a difference in length which makes that region eligible for substitutions in the longest 2S albumins and for addition of aminoacids in the shortest 2S albumins or for elongation of both. The same should be applicable at approximately of the end of the first third part of the same region between said sixth and seventh cysteine; see the sequence of R. communis which is much shorter at that region than the corresponding regions of the other exemplified 2S proteins.
It is of course realized that caution must be exercised against hypotheses based on arbitrary choices as concerns the bringing into line of similar parts of proteins which elsewhere exhibit substantiial differences.
Nevertheless such comparisons have proven in other domains of genetics to provide the man skilled in the art with appropriate guidance to reasonably infer from local structural differences, on the 920918,PHHDAT.129,44951-89.1et 11 WO 90/04032 PCT/EP89/01229' 12 one hand, and from local similarities, on the other hand, in similar proteins of different sources, which parts of such proteins can be modified and which parts cannot, when it is sought to preserve some basic properties of the non modified protein in the same protein yet locally modified by a foreign or heterologous sequence.
The choice of the adequate nonessential regions to be used in the process of the invention will also depend on the length of the polypeptide containing the appropriate aminoacids. Basically the method of the invention allows the modification of said 2S albumins by the insertion and/or partial substitution into the precursor nucleic acid of sequences encoding up to 100 aminoacids.
When the complJte protein sequence of the region to be inserted into a 2S albumin has been determined, the nucleotide sequence to encode said protein sequence must be determined. It will be recognized that while perhaps not absolutely necessary the codon usage of the encoding nucleic acid should where possible be similar to that of the gene being modified.
The person skilled in the art will have access to appropriate computer analysis tools to determine said codon usage.
Any appropriate genetic engineering technique may be used for substituting the insert for part of the selected precursor-coding nucleic acid or for inserting it in the appropriate region of said precursor-coding nucleic acid. The general in vitro recombination techniques followed by cloning in bacteria can be used for making the chimeric genes.
Site-directed mutagenesis can be used for the same purposes 0 as further exemplified hereafter. DNA recombinants, e.g.
plasmids suitable for the transformation of plant cells can also be produced according to techniques disclosed in current technical literature. The same applies finally to the production of transformed plant cells in which the hybrid 3torage protein encoded by the relevant parts of the selected WO 90/04032 PCT/EP89/01229 13 precursor-coding nucleic acid can be expressed. By way of example, reference can be made to the published European applications no. 116 718 or to International application WO 84/02913 and, which disclose appropriate techniques to that effect.
When designing the sequences rich in appropriate aminoacids, care must be taken that the resulting peptide containing said appropriate aminoacids does not influence the stability of the modified 2S albumin. Certain insertions may indeed disrupt the structure of the protein. For example, long stretches of methionines may result in rod shaped helices which would result in instabilities due to disruption of normal folding patterns. Thus such sequences must occasionally include aminoacids which interrupt the helical structure.
The procedures which have been disclosed hereabove apply to the adequate modification of the nonessential region of any of 2S albumins by an heterologous insert containing a DNA sequence encoding a peptide containing appropriate aminoacids with nutritional properties and then to the transformation of the relevant plants with the chimeric gene obtained for the production of a hybrid protein containing the sequence of said peptide in the cells of the relevant plant. Needless to say that the person skilled in the art will in all instances be able of selecting which of the existing techniques would at best fulfill its needs at the level of each step of the production of such modified plants, to achieve the best production yields of said hybrid storage protein.
For instance the following process can be used in order to exploit the capacity of a 2S albumin, to be used as a suitable vector for the production of plants with increased nutritional value, by inserting in said 2S albumins nucleotide codons encoding methionine and/or lysine and/or thryptophane and/or threonine and/or phenylalanine and/or leucine and/or valine and/or isoleucine when the corresponding WO 90/04032 PCT/EP89/01229 14 precursor-coding nucleic acid has been sequenced. Such process then comprises: 1) locating and selecting one of said relevant sequences of the precursor-coding nucleic acid which comprises a nonessential region encoding a peptide sequence which can be modified by substituting an insert for part of it or by inserting of said insert into it, which modification is compatible with the conservation of the configuration of said 2S' albumins and this preferable by determining the relative positions of the codons which encode the successive cysteine residues in the mature protein or protein subunits of said 2S albumins and identifying the corresponding successive nucleic acid regions located upstream of, between, and downstream of said codons within said sub-sequences of the precursor-coding nucleic acid and identifying in said successive regions those parts which undergo variability in either aminoacid sequence or length or both from one plant species to another as compared with those other regions which do exhibit substantial conservation of aminoacid sequence in said several plant species, one of said nucleotide regions being then selected for the insertion therein of the nucleic acid insert as described hereunder.
An alternative would consist of studying any 3-D structures which may become available in the future.
2)inserting a nucleic acid insert in the selected region of said precursor nucleic acid in appropriate reading frame relationship with the non-modified parts of said relevant sequence, which insert includes a determined segment encoding a peptide containing all or part of the above mentioned appropriate aminoacids.
3) inserting the modified precursor-coding nucleic acid obtained in a plasmid suitable for the transformation of 13 plant cells which can be regenerated into full WO 90/04032 PCT/EP89/01229 seed-forming plants, wherein said insertion is brought under the control of regulation elements, particularly a plant promoter capable of providing for the expression of the open reading-frames associated thee eith in said plants; 4) transforming a culture of such plant cell, with such modified plasmid; assaying the expression of the chimeric gene encoding the hybrid storage protein and, when achieved 6) regenerating said plants from the transformed plant cells obtained and growing said plants up to maturity.
In the case the chimeric gene is under the control of a seed specific promotor, growing up the transformed plants to seeds must precede step Hence embodiment as described under 1) of the invention hereabove provides that in having the hybrid 2S albumins in a plant, it will pass the plant protein disulfide isomerase during membrane translocation, thus increasing the chances that the correct disulfide bridges be formed in the hybrid precursor as in its normal precursor situation, on the one hand The invention further relates to the recombinant nucleic acids themselves for use in the process of the invention; particularly to the recombinant precursor encoding nucleic acid defined in the context of said process; recombinant nucleic acids containing said modified precursor encoding nucleic acid under the control of a plant promoter, whether the latter originates from the same DNA as that of said precursor coding nucleic acid or from another DNA of the same plant from which the precursor encoding nucleic acid is derived, or from a DNA of another plant, or from a non-plant organism provided that it is capable of directing gene expression in plants.
WO 90/04032 PCT/EP89/01229 16 vectors, more particularly plant plasmids e.g., Ti-derived plasmids modified by any of the preceding recombinant nucleic acids for use in the transformation of the above plant cells.
The invention also relates to the regenerable source of the hybrid 2S albumin, which is formed of in the cells of a seed-forming-plant, which plant cells are capable of being regenerated into the full plant or seeds of said seed-forming plants wherein said plants or seeds have been obtained as a result of one or several generations of the plants resulting from the regeneration of said plant cells, wherein further the DNA supporting the genetic information of said plant cells or seeds comprises a nucleic acid or part thereof, including the sequences encoding the signal peptide, which can be transcribed in the mRNA corresponding to the precursor of a 2S albumin of said plant, placed under the control of a plant specific promoter, and wherein said nucleic acid sequence contains a relevant modified sequence encoding the mature 2S storage protein or one of the several sub-sequences encoding for the corresponding one or several sub-units of said mature 2S albumins, wherein further the modification of said relevant sequence takes place in one of its nonessential regions and consists of a heterologous nucleic acid insert forming an open-reading frame in reading phase with non modified parts which surround said insert in the relevant sequence, wherein said insert consists of a nucleotide segment encoding a peptide containing methionine and/or lysine and/or thryptophane and/or threonine and/or phenylalanine, and/or leucine and/or valine and/or isoleucine.
It is to be considered that although the invention should not be deemed as being limited thereto, the nucleic inserts encoding the above mentioned appropriate aminoacids WO 90/04032 PCT/EP89/01229 17 will in most instances be man-made synthetic oligonucleotides or oligonucleotides derived from procaryotic or eucaryotic genes or of from cDNAs derived of procaryotic or eucaryotic RNAs, all of which shall normally escape any possibility of being inserted at the appropriate places of the plant cells or seeds of this invention through biological processes, whatever the nature thereof. In other words, these inserts are "non plant variety specific", specially in that they can be inserted in different kinds of plants which are genetically totally unrelated and thus incapable of exchanging any genetic material by standard biological processes, including natural hybridization processes.
Thus the invention further relates to the seed forming plants themselves which have been obtained from said transformed plant cells or seeds, which plants are characterized in that they carry said hybrid precursor-coding nucleic acids associated with a plant promoter in their cells, said inserts however being expressed and the corresponding hybrid protein produced in the cells of said plants.
There follows an outline of a preferred method which can be used for the modification of a 2S albumin gene and its expression in the seeds obtained from the transgenic plants.
The outline of the method given here is followed by a specif- 25 ic example. It will be understood from the person skilled in the art that the method can he suitably adapted for the modification of other 2S albumin genes.
1. Replacement or supplementation of the hypervariable region of the 2S albumin gene by a sequence encoding peptide containing appropriate aminoacids which possess nutritional properties.
Either the cDNA or the genomic clone of the 2S albumin can be used. Comparison of the sequences of the hypervariable regions of the genes in figure 2 shows that they vary in length. Therefore if the sequence encoding a peptide contain- WO 90/04032 PCT/EP89/01229 18 ing the appropriate aminoacids is short and a 2S albumin with a relatively short hypervariable region is used, said sequence of interest can be inserted. Otherwise part of the hypervariable region is removed, to be replaced by the insert containing a larger segment or sequence encoding the peptide containing the appropriate aminoacids. In either case the modified hybrid 2S albumin may be longer than the native one. In either case two standard techniques can be applied; convenient restriction sites can bn exploited, or mutagenesis vectors Stanssens et al. 1987) can be used. In both cases, care must be taken to maintain the reading frame of the message.
The sequence encoding the signal peptide of the precursor of the storage protein used either belongs to this precursor or can be a substitute sequence coding for the signal peptide or peptides of an heterologous storage protein.
2. The altered 2S albumin coding region is placed under the control of a plant promoter. Preferred promoters include the strong constitutive exogeneous plant promoters 20 such as the promoter from cauliflower mozaic virus directing the 35S transcript (Odell, J.T. et al., 1985), also called the 35S promoter; the 35S promoter from the CAMV isolate Cabb-JI (Hull and Howell, 1987), also called the 35S3 promoter; the bidirectional TR promoter which drives the expression of both the 1' and the 2' genes of the T-DNA (Velten et al., 1984).
Alternatively a promoter can be utilized which is not constitutive but specific for one or more tissues or organs of the plant. Given by way of example such kind promoters may be the light inducible promoter of the ribulose-l, 5-bi-phosphate carboxylase small subunit gene (US patent application 821, 582), if the expression is desired in tissue with photosynthetic activity, or may be seed specific promoters.
WO 90/04032 PCI/EP89/01229 19 A seed specific promoter is used in order to ensure subsequent expression in the seeds only. This may be of particular use, since seeds constitute an important food or feed source. Moreover, this specific expression avoids possible stresses on other parts of the plant. In principle the promoter of the modified 2S albumin can be used. But this is not necessary. Any other promoter serving the same purpose can be used. The promoter may be chosen according to its level of efficiency in the plant species to be transformed.
In the examples below the 2S albumin promoter from the 2S albumin gene from Arabidopsis is used, which constitutes the natural promotor of the 2S albumin gene which is modified I', said examples. Needless to say that other seed specific promotors may be used, such as the conglycinine promotor from soybean. If a chimeric gene is so constructed, a signal peptide encoding region must also be included, either from the modified gene or from the gene whose promotor is being used.
The actual construction of the chimeric gene is done using standard molecular biological techniques described in Maniatis et al., 1982. (see example).
3. The chimeric gene construction is transferred into the appropriate host plant.
When the chimeric or modified gene construction is complete it is transferred in its entirety to a plant transformation vector. A wide variety of these, based on disarmed (non-oncogenic) Ti-plasmids derived from Aqrobacterium tumefaciens, are available, both of the binary and cointegration forms (De Blaere et al., 1987). A vector including a selectable marker for transformation, usually antibiotic resistance, should be chosen. Similarly, the methods of plant transformation are also numerous, and are fitted to the individual plant. Most are based on either protoplast transformation (Marton et al., 1979) or formation of a small piece of tissue from the adult plant (Horsch et al., 1985).
12 In the example below, the vector is a binary disarmed WO 90/04032 PCT/EP89/01229 Ti-plasmid vector, the marker is kanamycin resistance, and the leaf disc method of transformation is used.
Calli from the transformation procedure are selected on the basis of the selectable marker and ,-'generated to adult plants by appropriate hormone induction. This again varies with the plant species being used. Regenerated plants are then used to set up a stable line from which seeds can be harvested.
Further characteristics of the invention will appear in the course of the non-limiting disclosure of specific examples, particularly on the basis of the drawings in which: Figs. 1, 2 and 3 refer to overall features of 2S-albumins as already discussed above. The numbers refer to the number of aminoacids observed in the different fragments of the protein precursor.
Fig. 4 represents the sequence of 1kb fragment containing the Arabidopsis thaliana 2S albumin gene and shows related elements.' The Ndel site is underlined.
Fig. 5 provides the protein sequence of the large subunit of the above Arabidopsis 2S protein together with related oligonucleotide sequences.
Fig. 6A shows diagrammatically the successive phases of the construction of a chimeric 2S albumin Arabidopis thaliania gene including the deletion of practically all parts of the hypervariable region and its replacement by a AccI site, the insertion of DNA sequences rich in methionine codons, given by way of of example in the following disclosure, in the AccI site, particularly through site-directed mutagenesis and the cloning of said chimeric gene in plant vector suitable for plant transformation.
Fig. 65 shows diagrammatically the protein sequence of the large subunit of several ArabidoDsis 2S albumins and indicates the region removed from the genes WO 90/04032 PCT/EP89/01229 21 encoding said 2S albumins, and shows diagrammatically where an AccI site has been created and how oligonucleotides rich in methionine codons are inserted into said AccI site in such a way that the open reading frame is maintained.
Fig 7 diagrammatically compares the protein sequences of the large subunits of the unmodified 2S albumin, in which most of the hypervariable region has been deleted, and those of the modified 2S albumins. The resulting number of methionine residues are indicated.
Fig. 8 shows the restriction sites and genetic map of a plasmid suitable for the performance of the above site-directed mutagenesis.
Fig. 9 shows diagrammatically the different steps of the site-directed mutagseesis procedure of Stanssens et al (1987) as generally applicable to the modification of nucleic acid at appropriate places.
Fig. 10 gives the restriction map of pGSC1703A.
Example I As a first example of the method described, a procedure .is given for the production of transgenic plant seeds with 25 increased nutritional value by having inserted into their genome a modified 2S albumin protein from Arabidopsis thaliana having deleted its hypervariable region and replaced by way of example by a methionine rich peptide having 7 aminoacids with the following sequence :I M M M M R M. A synthetic oligomer encoding said peptide is substituted for essentially the entire part of the hypervariable region in a genomic clone encoding the 2S albumin of Arabidopsis thaliana. Only a few aminoacids adjacent to the sixth and seventh cysteine residues remained. This chimeric gene is under the control of its natural promoter and WO 90/04032 PCIT/EP89/01229 22 signal peptide. The process and constructions are diagrammatically illustrated in Fig. GA, 6B and 7. The entire construct is transferred to tobacco, Arabidopsis thaliana and Brassica napus plants using an Agrobacterium mediated transformation system. Brassica napus is of particular interest, since this crop is widely used as protein source for animal feed.
Plants irs regenerated, and after flowering the seeds are colleo~ad and the methionine content compared with untransformrd plants.
1. Cloning of the Arabidopsis thaliana 2S albumin gene.
The Arabidopsis thaliana gene has been cloned according to what is described in Krebbers et al., 1988. The plasmid containing said gene is called pAT2S1. The sequence of the region containing the gene, which is called AT2S1, is shown in figure 4.
Deletion of the hypervariable region of AT2S1 gene and replacement by an AccI site.
Part of the hypervariable region of AT2S1 is replaced by the following oligonucleotide: CCA ACC TTG AAA GGT ATA CAC TTG CCC AAC 3' P T L K G I H L P N in which the underlined sequences represent the AccI site and the surrounding ones sequences complementary to the coding sequence of the hypervariable region of the Arabidopsis 2S albumin gene to be retained. This results finally in the aminoacid sequence indicated under the oligonucleotide.
WO 90/04032 PCT/EP89/01229 23 The deletion and substitution of part of the sequence encoding the hypervariable region of AT2S1 is done using site directed mutagenesis with the oligonucleotide as primer. The system of Stanssens et al. (1987) is used.
The Stanssens et al. method is described in EP 87 402 384.4.
It makes use of plasmid pMac5-8 whose rsa_-iction and genetic map and the positions of the relevant genetic loci are shown in Fig. 8. The arrows denote their functional orientation.
fdT: central transcription terminator of phage fd; Fi-ORI: 0 origin of replication of filamentous phage fl; ORI: ColEl-type origin of replication; BLA/ApR region coding for B-lactamase; CAT/CmR region coding for chloramphenicol acetyl transferase. The positions of the amber mutations present in pMc5-8 (the bla-am gene does not contain the Scal site) and pMc5-8 (cat-am; the mutation eliminates the unique PvuII site) are indicated. Suppression of the a amber mutation in both gsu ard supF hosts results in resistance to at least ug/ml Cm. pMc5-8 confers resistance to ±20 ug/ml and 100 ug/ml Ap upon amber-suppression in supE and suPF strains respectively. The EcoRI, Ball and NcoI sites present in the w.ld-type cat gene (indicated with an asterisk) have been removed using mutagenesis techniques.
Essentially the mutagenesis round used for the above men- 25 tioned substitution is ran as follows. Reference is made to Fig. 9, in which the amber mutations in the Ap and Cm selectable markers are shown by closed circles. The symbo l represents the mutagenic oligonucleotide. The mutatej itsejf is indicated by an arrowhead.
The individual steps of the process are as follows: Cloning of the HindIII fragment of pAT2S1 containing the coding region of the AT2S1 gene into pMa5-8 This vector carries on amber mutation in the CmR gene and WO 90/04032 PCT/EP8910 1229 24 specifies resistance to ampicillin. The resulting plasmid is designated pMacAT2Sl (see figure 6A step 1).
Preparation of single stranded DNA of this recombinant (II) from pseudoviral particles.
Preparation of a HindIII restriction fragment from the complementary pMc type plasmid (III). pMc-type vectors contain the wild type CmR gene while an amber mutation is incorporated in the Ap resistance marker.
Construction of gap duplex DNA (hereinafter called gdDNA) gdDNA (IV) by ji vitro DNA/DNA hybridization. In the gCDNA the target sequences are exposed as single stranded DNA. Preparative purification of the gdDNA from the other components of the hybridization mixture is not necessary.
Annealing of the 30-mer synthetic oligonucleotide to the gdDNA Filling in the remaining single stranded gaps and sealing of the nicks by a simultaneous .in vitro Klenow DNA polymerase I DNA ligase reaction (VI).
Transformation of a mutS host, a strain deficient in mismatch repair, selecting for Cm resistance. This results in production of a mixed plasmid progeny (VII).
Elimination of progeny deriving from the template strand 25 (pMa-type) by retransformation of a host unable to suppress amber mutations (VIII). Selection for Cm resistance results in enrichment of the progeny derived from the gapped strand, the strand into which the mutagenic oligonucleotide has been incorporated.
Screening of the clones resulting from the retransformation for the presence of the desired mutation. The resulting plasmid containing the deleted hypervariable region of AT2S1 is called pMacAT2S1C40 (see figure 6A step 2).
WO 90/04032 PCT/EP89/01229 3. Insertion of sequences rich in methionina codons into the AT2S1 gene whose sequences encoding the hvpervariable reion have been deleted.
stated above when the sequences encoding most of the hypervariable loop were removed an AccI site was inserted in its place. The sequences >f interest will be inserted into this AccI site, but a second AccI site is also present in the HindIII fragment containing the modified gene. Therefore the NdeI-HindIII fragment containing the modified gene is subcloned into the cloning vector pBR322 (Bolivar, 1977) also cut with Ndel and HindIII. The position of the NdeI site in the 2S albumin gene is indicated in figure 4. The resulting subclone is designated pBRAT2S1 (Figure 6A, step 3).
In principle any insert desired'can be inserted into the AccI site in pBRAT2Sl. In the present example said insert encodes the following sequence: I.M.M.M.M.R.M. Therefore complementary oligonucleotides encoding said peptide are synthesized taking into account the codon usage of AT2S1 and ensuring the the ends of the two complementary oligonucleotides are complementary to the staggered ends of the AccI site, as shown here (the oligonucleotides are shown in bold type) GT ATA ATG ATG ATG ATG CGC ATG ATAC 3' 3' CA TAT TC TAC TAC TAC GCG TAC TATG The details of this insertion, showing how the reading frame is maintained, are shown in figure 6B. The two oligonucleotides are annealed and ligated with pBRAT2S1 digested with AccI (figure 6A, step The resulting plasmid is designated pAD4.
WO 90/04032 PCT1/EP89/01229 26 4. Reconstruction of the complete modified AT2S1 gene with its natural promoter.
The complete chimeric gene is reconstructed as follows (see figure 6A): The clone pAT2S1Bg contains a 3.6kb BglII fragment inserted in the cloning vector pJB65 (Botterman et al., 1987) which encompasses not only the 1.0kb HindIII fragment containing the coding region of the gene AT2S1 but sufficient sequences upstream and downstream of this fragment to contain all necessary regulatory elements for the proper expression of the gene. This plasmid is cut with HindIII and the 5.2kb fragment that portion of the plasmid not containing the coding region of AT2S1) is isolatec, The clone pAT2S1 is cut with HindIII and NdeI and the resulting 320 bp HindIII-NdeI fragment is isolated. This fragment represents the one removed from the modified 2S albumin in the construction of pBRAT2S1 (step 3 of figure 6A) in order to allow the insertion of the oligonucleotides in step 4 of figure SA to proceed without the complications of an extra AccI site. These two isolated fragments are then ligated in a three way ligation with the NdeI-HindIII fragment forom pAD4 (figure 6A, step 5) containing the modified coding sequence.
Individual tranformants can be screened to check for appropriate orientation of the reconstructed HindIII fragment within the BglII fragment using any of a number of sites. The resulting plasmid, pAD17, consists of a 2S albumin gene modified only in the hypervariable region, surrounded by the same flanking sequences and thus the same promoter as the unmodified gene, the entirety contained on a BglII fragment.
Tranasformation of plants.
The BglII fragment containing the chimeric gene is inserted into the BglII site of the binary vector pGSC1703A (Fig. 10) (see also Fig. 6A step The resultant plasmid is designated pTAD12. Vector pGSC1703A contains functions 'NO 90/0403 2 PCT/EP89/01229 27 for selection and stability in both E. goli and A. tunmaciens, as well as a T-DNA fragment for the transfer of foreign DNA into plant genomes (Deblaere et al., 1987). It further contains the bi-directional TR promotor (Velten et al., 1984) with the neomycin phosphotransferase protein coding region (neo) and the 3' end of the ocs gene on one side, and a hygromycin transferase gene on the other side, so that transformed plants are both kanamycin and hygromycin resistant. This plasmid does not carry an ampicillin resistance 10 gene, so that carbenicillin as well as claforan can be used to kill Agrobacterium after the infection step. Using standard procedures (Deblaere et al., 1987), pTAD12 is transferred to the Agrobacterium strain C58C1Rif carrying the plasmid pMP90 (Koncz and Schell, 1986). The latter provides in trans the vir gene functions required for successful transfer of the T-DNA Aegion to the plant genome. This Agrobacterium is then used to transform plants. Tobacco plants of the strain SR1 are transformed using standard procedures (Deblaere et al., 1987). Calli are selected on 100 ug/ml kanamycin, and resistant calli used to regenerate plants.
The techniques for transformation of Arabidopsis thaliana and Brassica napus are such that exactly the same construction, in the same vector', can be used. After mobilization to Agrobacterium tumefaciens as described hereabove, the procedures of Lloyd et al., (1986) and Klimaszewska et al. (1985) are used for transformation of Arabidopsis and Brassica respectively. In each case, as for tobacco, calli can be selected on 100 ug/ml kanamycin, and resistant calli used to regenerate plants.
In the case of all three species at an early stage of regeneration the regenerants are checked for transformation by inducing callus from leaf on media supplemented with kanamycin (see also point 6).
6. Screening and analysis of transformed plants.
WO 90/04032 PCT/EP89/01229 28 In the case of all three species, regenerated plants are grown to seed. Since different transformed plants can be expected to have varying levels of expression ("position effects", Jones et al., 1985), more than one tranformant must initially be analyzed. This can in principle be done at either the RNA or protein level; in this case seed RNA was prepared as described (Beachy et al., 1985) and northern blots carried out using standard techniques (Thomas et al., 1980). Since in the case of both Brassica and Arabidopsis the use of the entire chimeric gene would result in cross hybridization with endogeneous genes, oligonucleotide probes complementary to the insertion within the 2S albumin were used; the same probe as used to make the construction can be used. For each species, 1 or 2 individual plants were chosen for further analysis as discussed below.
First the copy number of the chimeric gene is determined by preparing DNA from leaf tissue of the transformed plants (Dellaporta et al., 1983) and probing with the oligonucleotide used above.
The methionine content of the seeds is analyzed using known methods (Joseph and Marsden, 1986; Gehrke et al., 1985; Elkin and Griffith, 1985 and Example II As a second example of the method described, the same procedure is followed for the production of transgenic plant seeds with increased nutritional value by having inserted into their genome a modified 2S albumin protein from Arabidopsis thaliana having deleted its hypervariable region and replaced by way of example by a methionine rich peptide having 24 aminoacids with the following sequence WO 90/04032 PCY/E P89/01229 29
IMMMQPRGDMMMIMMMQPRGMMM
All different steps going from constructs to transformants as disclosed for example I are executed with the only difference that in step 3 the following oligonucleotide has been synthesized and inserted into pBrAT2S1 (the oligonucleotides are shown in bold type) GT ATA ATG ATG ATG CAA CCA AGG GGC GAT ATG ATG ATG ATA ATG ATG ATG 3' CA TAT TAC TAC TAC GTT GGT TCC CCG GTA TAC TAC TAC TAT TAC TAC TAC CAA CCA AGG GGC GAT ATG ATG ATG ATA C 3' GTT GGT TCC CCG CTA TAC TAC TAC TAT G The relevant plasmids are indicated in figure 6A, details of the insertion in figure 6B and resulting aminoacid sequence of the hybrid subunit shown in figure 7. The relevant plasmids as indicated in figure 6A are pAD3, pAD7 and The examples have thus given a complete illustration of how 2S albumin storage proteins can be modified to incorporate therein an insert encoding a methionine rich polypeptide followed by the transformation of plant cells such as tobacco cells, Arabidopsis cells and Brassica nanus cells with an appropriate plasmid containing the corresponding modified precursor nucleic acid, the regeneration of the transformed plant cells into corresponding plants, the culture thereof up to the seed forming stage, the recovery of the seeds and finally the analysis of the methionine content of said seeds compared with the seeds of corresponding non transformed plants.
It goes without saying that the invention is not limited to the above examples. The person skilled in the art will in each case be able to choose the desired combination of appropriate aminoacids to be inserted into the hypervariable region of the 2S storage protein, in function of the plant he wants to improve with regard to its nutritional value and in function of the desired application of the modified plant.
There follows a list of bibliographic references which have been referred to in the course of the present disclosure to the extent when reference has been made to known methods for achieving some of the process steps referred to herein or to general knowledge which has been established prior to the performance of this invention. All of the said articles are incorporated herein by reference.
It is further confirmed that plasmid pAT2Sl has been deposited with the DSM under No. 4879 on October 7, 1988 plasmids pMa5-8 and pMc5-8 have been deposited with the DSM under No. 4567 and 4566, respectively on May 3, 1988 plasmid pAT2S1Bg has been deposited with the DSM under No. 4878 on October 7, 1988 -plasmid pGSC1703a has been deposited with the DSM under No. 4880 on October 7, 1988 notwithstanding the fact that they all consist of constructs that the person skilled in the art can reproduce them from available genetic material without performing any inventive work.
920218,cjhda.073,4495 1,le WO 90/04032 WO 9004032PCT/EP89/0 1229 3,1 Ref erence~ Altenbach, Pearson, Leung, Sun, S.S.M (1987) Plant Mol. Biol. 1, 239-250.
Ampe Van Dammne, de Castro, Sampaio, Van Montagu, M. and Vandekerckhove, J. (1986) Eur.
J. Biochem. 1J, 597-604.
Beachy, Chen, Horsch, Rogers, Hoffman, N.J. and Fraley, R.T. (1985) EMY5O J. A, 3047-3053.
Bergman, L.W. and Kuehl, W.N. (1979) J. Biol. Chem. 5690-5694.
Blobel, (1L980) Proc. Natl. Acad. Sci. 77, 1496-1500.
Bolivar, Rodriguez, Greene, Betlach, M.C., Heynecker, Boyer, Crosa, J.H. and Falkow, S.
(1977) Gene 2Z, Botterman, J. and Zabeau, M. (1987) DNA A, 583-591.
Brown, J. (1976) Fed. Proc. Am. Soc. Exp. Biol. 2141-2144.
Brown, Wandelt, Chx., Maier, Dietrich, G., Schwall, N. and Feix, G. (1986) EMBO workshop "Plant Storage Protein Genes" Program and Abstracts page 19, Eds. J.
Brown and G. Feix, University of Freiburg, 1986.
Chee, Kiassy, R.C. and Slightom, J.L. (1986) Gene Al, 47-57.
Chrispeels, N.J. (1983) Plantki 15a, 140-152.
Craig, S. and Goodchild, D.J. (1984) Protoplasma 35-44 Crouch, Tembarge, Simon, A.E. and Feri, R.
(1983) J. Mol. Appi. Gen. Z, 273-283.
De Blaere, Reyrnaerts, Hofte, Hernaisteens, Leemans, J. and Van Montagu, M. (1987) Methods in Enzymology ;53, 277-291 De Castro, Lacerada, Aramayo, Sampaio, M.J.A.M. and Gander, E.S. (1987) Mol. Gen. Genet. 206, 338-343.
WO 90/04032 WO 9004032PCT/EP89/01229 32 Dellaporta Wood, J. and Hicks, B. (1983) Plant Molecular Biology Reports 1,l 19-21.
Ellis, Shirsat, Hepher, Yarwood, Gatehouse, Croy, R.R.D. and Boulter, D. (1988) Plant Molecular Biology 203-214.
Elkin, and Griffith, J.E. (1985a) J. Assoc. Off. Anal.
Chem. 68, 1028-1032.
Elkin, and Griffith, J.E. (1985b) J. Assoc. Off. Anal.
Chem. 68, 1117-1127.
Ericson, Rodin, Lenman, Glimeliums, K., Lars-Goran, J. and Raic, L. (1986) J. Biol. Chem. 261 14 576-14 581.
Greenwood, J.S. and Chrispeels, M.J. (1985) Plant Physiol.
79, 65-71.
Gehrke, Wall, Absheer, Kaiser, F.E. and Zumwalt, R.W. (1985) J. Assoc. Off. Anal. Chem. 68, 811-821.
Herman, Shannon, L.M. and Chrispeels, M.J. (1986) In Molecular Bioloqv of Seed Storage Proteins and Lecting, L.M.
Shannon and M.J. Chrispeels Eds., American Society of Plant Physiologists.
Higgins, T.J.V. (1984) Ann. Rev. Plant Physiol. 191-221.
Higgins, Llewellyn, Newbigin, E. and Spencer, D.
(1986) EMBO workshop "Plant Storage Protein Genes" Program and abstract page 19, Eds. J. Brown and G. Feix, University, of Freiburg, 1986.
Horsch, Fry, Hoffmanni, Eichholtz, D., Rogers, S.G. and Fraley, R.T. (1985) Science 2,27, 1229-1231.
Hoffman, Donaldson, Bookland, Rashka, K., Herman, E.M. (1987) EMBO J. A, 3213-3221.
Hull and Howell (1987) Virology, 86, 482-493 Jagodinski, Sargent, Yang, Glackin, Boizner, J. (1987) Proc. Natl. Acad. Sci. USA. 78, 3521-3525.
Jones Dunsmuir, P. and Bedbrook, J. (1985) EMBO J. 4 2411-2418.
WO 90/04032 PCr/EP89/01229 33 Joseph, H. and Marsden, J. (1986) "IHPLC of Small Molecules A practical approach" in: IRL Press oxford Washington D.C.
"Amino Acids and Small Peptides" Ed.: Kim 13-27.
Josefsson, Lenman, Ericson, H.L. and Rask,L.
(1987). J. Biol. Chem. 12196-12201.
Kliiaaszewska, K. and Keller, W.A. (1985) Plant Cell Tissue Organ Culture, A, 183-197.
Krebbers, Herdies, De Clercq, Seuriflck, J., Leemans, Vandamme, Segcjura, Gheysen, Van Montagu M. and Vandekerckhove, J. (1988) Plant Physiol.
87 859-866.
Koncz, C. and Schell, J. (1986) Mol. Gen. Genet. 204,J 383-396.
Larkins B.A. and Hurkman,W.J. (1978) Plant Physiol. 62, 256-263.
Lloyd, Barnason, Rogers, Byrne, M.C., Fraley, R.T. and Horsh, R.B. (1986) Science 464-466.
Lord, J.M. (1985). Eur. J. Biochem. ,403-409.
Maniatis, Fritsch, E.F. and Sambrook, J. (1982) Molecular Cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor,New York.
Marris, Gallois, Copley, J. and Kreis, N. (1988) Plant Molecular Biology .10, 359-366.
Marton, Wullems, Molendijk, L. and Schilperoort, R.A. (1979) Nature, 2772, 129-131.
Morinaga, Sakai, Wegmann, Tanaoki, T. (1983) Proc. Natl. Acad. Sci. 80l. 4604-4606.
Odell, Nagy, J. and Chua, N.M.(1985) Nature 313, 810-812.
Okamuro, Jofuku, K.D. and Goldberg, R.B. (1986) Piroc.
Natl. Acad. Sci. USA. 83, 8240-8244.
Perlman, D. and Halvorson, H.O. (1983) J. Mol. Bio~l. 167, 391-409.
WO 90/04032 WO 9004032PCT/EP89/01 229 34 Radke, Andrews, Moloney, Crouch, M.L.
Kridl, J.C. and Xnauf, V.C. (1988) Theor. Appi. Geniet. 685-694.
Roden, Miflin, Freedman, R.B. (1982) FEBS Lett.
138, 121-124.
Scofield, S.R. and Crouch, M.L. (1987) J. Biol. Chem. Z6Z 12202-12208.
Seng-upta-Gopalan, Reichert, Barker, Hall, T.C. and Kemp, J.D. (1985) Proc. Natl. Acad. Sci. USA 82Z, 3320-3324.
Sharief, S.F. and Steven, (1982) J. Biol. Chem.
Z57(24), 14753-14795.
Slightom, J.L. and Chee, P.P. (1987) Biotechn. Adv. 29-45.
Stanssens, McKeown, Friedrich, and Fritz, H.J.
(1987) Manual EMBO Laboratory course; 'Directed mutagensis and protein engineering' held at Max Planck Institute f=Lr Biochemie, Martinsried, W-Germany, July 4-18, 1987.
Staswick, (1988) Plant Physiol. 87, 250-254.
Thomas, P.S. (1980) Proc. Natl. Acad. Sci. 5201.
Velten, Velten, Hain, R. and Schell, J. (1984) EMBO J. 32, 2723-2730 Walling, Drews, G.M. and Goldberg, R. (1986) Proc. Natl.
Acad. Sci. g3, 2123-2127.
Yang, Luna, McAnelly, Noberhaus, Cuppies, Bowman, B.H. (1985) Nucl. Acids Res. 13, 8007-8017.
Youle, R. and Huang, A.H.C. (1981) American J. Bot. 68, 44-48.
WO 90/04032 PTE8/12 PC]'/EI'89/01229 2S Albumin As Of Total Seed Protein TABLE I Family, species% (common name) Compositae 1-elianthus annuus (sunflower) 62 C ruci ferae Brassica spp.
(mustard) 62 Linaceae Lin urn usitatissirnurn (linseed) 42 Leguminosae Lupinus polyphyllus (lupin) 38 Arachis hypogaea (peanut) Lecythidaceae Bertlzolletia excelsa (brazil nut) Lii iaceae Yucca spp.
(yucca) 27 Euphorbiaceae Ricinus communis (castor bean) '44 From Youle and Huang, 1991

Claims (13)

1. A seed-forming plant which is capable of producing all or part of a 2S albumin and the genome of which contains a recombinant DNA consisting essentially of: a first DNA sequence that encodes said all or part of said 2S albumin and that is under the control of a promoter capable of directing expression of said first DNA sequence in said plant; and a nucleic acid insert that encodes an essential amino acid, that is located in said first DNA sequence, and that forms an open reading frame in reading phase with said first DNA sequence; said insert being located in a non-essential region of said first DNA sequence between codons which code for the sixth and seventh cysteine residues of said 2S albumin.
2. The plant of claim 1, wherein said non-essential region starts three codons downstream of said codon encoding said sixth cysteine residue and ends three codons upstream of said codon encoding said seventh cysteine residue.
3. The plant of claim 2, wherein said insert is located between codons which code for amino acids 31 and 57 of the large subunit of a 2S albumin of Arabidopsis thaliana.
4. The plant of claim 2, wherein said non-essential region starts six codons downstream of said codon encoding said sixth cysteine residue and ends six codons upstream of said codon encoding said seventh cysteine residue. 37 The plant of any one of claims 1-4, wherein the genome of said plant also contains a second DNA sequence that encodes a signal peptide and that forms an open reading frame with said first DNA sequence; said first and second DNA sequences being under the control of said promoter.
6. The plant of claim 5, wherein said first and second DNA sequences encode a precursor of said all or part of said 2S albumin of said plant.
7. The plant of any one of claims 1-6, wherein said 2S albumin is selected from the group consisting of 2S albumins of Ricinus communis, Arabidopsis thaliana, Brassica napus and Bertholletia excelsa.
8. The plant of any one of claims 1-7 which is an Arabidopsis or Brassica.
9. The plant of claim 8 which is Brassica napus. The plant of any one of claims 1-9, wherein said insert encodes a lysine, methionine, tryptophan, threonine, phenylalanine, leucine, valine, arginine and/or isoleucine moiety.
11. The plant of claim 10, wherein said insert encodes a plurality of said moieties.
12. A cell or a seed of the plant of any one of claims 1-11.
13. All or part of the 2S albumin produced by the plant, cell or seed of any one of claims 1-12.
14. The recombinant DNA of any one of claims 1-11. V Jjr 38 The genome of the plant of any one of claims 1-11 comprising said recombinant DNA.
16. A process for producing a transgenic seed-forming plant with increased nutritional value, which comprises the step of cultivating the plant of any one of claims 1-11. DATED this .8thday of February, 1992 Plant Geneti. Systems N.V. and Empresa Brasileira de Pesquisa Agropecuaria By Their Patent Attorneys DAVIES COLLISON CAVE 11IU M Organization of 2S Albumiin Precursors Comparison. of protein and nucleic acid sequences reveals that -the preproprotein is processed at ive points. Signal peptide A.T.P.F. Small Subunit 1.P.F. Large Subunit C.T. P.F. A rabidopsis Jirassica Ber-thollefia 21 16 36 10 79 2 21 16 29,35 19 86 1 F 22 14 34 5 73 4 A.T.P.F. =amino terminal processed fragment 1.P.F. internal processed fragment C.T.P.F. =carboxyl terminal processed fragment rq ~FIGURE 0 WO f"0/04032 P~T/EP89/0 1229 2/11 COM'PAP:S. .F 2S ALBUK:N PRECURSOR PROTEIN SEQUENCES Signal Peptice FIG. 2 B. exce, M A K 1S V A A A A L L. V M A L G H A T A (22) 3.2S nau A N K L. F 1.V C AAT L A L F F L L T N4 A A-.2S2 )A N KL FL VC A f[A L-C F L N A AT2S3 M A N K L. F L V C A T L A L. C F L L. T N A AT2S4 M A NK LFL VC ATALAL-C TN A' Ami.:^ Termninal Processed Fragmen~t B. exce. V RAT 7TT v E E EN (4 B. Napus 5 Y R TV ;7 ZE D A T N14 A72S' S IY R TV V EF E E DAT N A72S2 S1 R T VV ZF TE DODA TN A7253 S I Y R7V V EF E D DAS N AT2S4 S. T VVE F E 00A S N Srra2 Sjctunit -S QCG C R GC I0 E C.QN LR B. E C R e0 MQR%0OQ011m, FEH)I E B. raPuls S A G P F R I P K C R X tF-TN0) 2 1 G P K M P. K C R K E: F 0 KEQ H 1- R A ATMS PF ME G P- R K C VK EF QH L RA C A2G, WP -ILQCQS QQHPAC AT254 I G 1 0K C K EF 9_ )Q H L R A C R. CTrri Y 9 0 G P R. P (34) B. exce. TLZ _U (28 B. napus Wf S JSGL (35, 29 A72S1 LjQ R Q- GR 0 (36) AT2S2 L KM0 M R 0-G RG G AT2S3 7 NEDK 0M R -G R GG AT2S4 W MR K Q G RG G rna I Processed Fragment B. excel. P Y Q T1 H B. napus G G P N F D 5 F 0 F E D D M. E N AT 2 S:Z -GP--S L 0 S F 0 LT E 0 0 1 E AT23 -CP S L D E F D (4 AT2S4 G-IS L D 0E FDM EDD IE N Large Subunit. exce. R R GN~ 4 NPM SCQ C C E Q LC E B, nap'.s P Q P P LL C C L H E P 0 Gg]0 E 0L 0 Q C C'L 0--CC? ATNS2 0OG P0QG p OC C S ELRQ- -EP A72e3 M71 GP G L LQQC C NCL R EE R. comm. R C EG L R Q- 0L Q B. excel. -C RCCEG L R FNH MR MQLr m R B. napus L CV C P T L KG S K a QQa0 Q AT2SI OCV CPT L KQ-AA K AV RL 0G Q- H 0P H AT2S2 V C VCP T LRQ0A A RA V SLQ0GQ- H GP IF0 A72S3 V C V C P T L KQ XR X1S L0GQ0-H G PF Q AT2S4 IVC VC PTL R 0A A KA V R OG 0 09 P 0n ccrnzm. fFl--N V F EA FR TA ANLP S CG VS B. excel. I Q M R P M M RmA E v P S RC L SP B. napus G KQ 0M VmR Q-TA T HTIFP C N P Av2S WKI YOT AK HL P V)-P 0 Y KTA K YL PN IC K -Q A K Y LA P N I C K comm. 0--CRF (1 B. excel, CPG GS (73) B. napus VS WC P F jK H G (B 6) A:72S V 0 V C P F N I P S F P S (9 AT 2S2 V E C P F TT I P F F P P A72S3 V G E C P F 0 T T I P F F P P AT2S4 V G V C P F Q I Carooxyl Terminal Processed Fr&9ment B. excel. 2A G F (4) napus (1 A72S. T1171 2 A72S2 7 A72S3 y yS [ICT/EP"89/0 1229 WO 90/04032 3 /11 FIGURE 3 SMALL SUBUNIT S IGNAL I Y. C P.F. LARGE SUBUNIT WO 90/04032 PCT/E P89/0l1229 4 /i 1 FIGURE 4 ATCTTTATCCA -421 TATATTGTCTTACCATCAATAGACAATATCCAATGGACCCTGACCTGCGTGTATAAGTA -361 ATTTTTCAAGATGCAAAACTTTTATGTATTTCAGAATTAACCTCCAAAAACATTTATTG -301 ACACACTACTACTCTTTCCGTATTGACTCTCACTAGTCATTTCAAAATAATTGACATG3T -241 CAGAACATGAGTTA~tACATGGTTGCATATTGCAAGTAGACGCGGAAACTTGTCACTTCCT -181 TTACA TTTGAGTTTCC-AACACCTAATCACGACAACAATCATATAGCTCTCGCATACAAAC -121 AAA CA TATGCATGTATTCTTACACGTGAACTCCATGCAAGTCTCTTTTCTCACCTATAAA -61 TA CCAACCA CACCTTCACCACATTCTTCACTCGAACCAAAACATACACACATAGCAAAAA -1 M A N K L F L V C A A L A L C F L L T N ATGGCAAkACAAGTTGTTCCTCGTCTC;CGCAGCTCTCGCTCTCTGCTTCCTCCTCACCAAC A S I Y R T V V F E E D D A T N *P I G GC:TTCCATCTACCGCACCGTCGTTGAGTTCGAAGAAGATGACGCCACTAACCCCATAGGC 120 p K M. R K C R K E P Q K E 0 H L R A C Q0 CCAAAAATAGGAMTGCCCAAGGAGTTTCAGAAAGAACAACACCTAAGAGCTTGCCAG 1$~0 *Processed Q L M L Q Q A R Q G R S D *E F D F E D D CAATTGATGCTCCCAGCAAGC-AAGGCA.AGGCCGTAGCGATGAGTTTGATTTCGAAGACGAC 240 Large subunit M E N *P Q GQQQ EQQ0L F QQC C NE 100 ATGGAGAACCCACAGGGACACAGCAGGAACAACAGCTATTCCAGCAGTGCTGCAACGAG 300 L R Q E E P D C V C P T L K 0 A A K A V 120 CTTCGCCAGGAAGAGCCAGATTGTGTTTGCCCCACCTTGAAACAAGCTGCCA-AGGCCGTT 360 oligonucleotide 5 '-CAAGCTGCCAAGTACOGT -K Y G R L Q G Q H 0 P MoQ V R K I Y 0 T A K H 140 AGA CT C CAGGGA CAGCA CCA.ACCAATGCAAGTCAGGAAAATTTACCAG;ACAGCCAAGCAC 420 GGATTCTTGAAGCAGCACCAAC-3' oligo G F L K End mat. 1g. su.* L N V C D I P0Q V D V C P F N I' P S F 160 TTGCCCAACGTTTGCCACATCCCGCAkAGTTGATGTTTGTCCCTTCAACATCCCTTCATTC 480 P S F Y~ 0 164 CCTTCTTTCTACTAAATCTCAAACAAACCCTCAAAGCGTATAGAGTGTGGTTGTTGATA 540 TATACATGTTGACACTTGACACATACCACACCTCATCGTGTGTTTTATGATAAATGT WO 90/04032 I)Cr/EP89/01229 5111 FIGURE p- 0 a Q Q E Q 0 L F 0 Q C C N E L R Q E GGICAICAICAIGAICAICAI ITITTXCAICAITGITGIAkAIGA E P D C V C P T L X Q A A K A V R LOQG Q AAICAIGCIGCIAAIGC.IGTIIGIITICAIGGICAI HOQ p. PM QV R K I Y QT A K H L P N V C D CA I CA CCIAAIGTITGIGAI I p Q V D V C P F N P ATICCICAIGTIGAIGTITGICCITTIAkAICC WO 90/04032 PTE8/)12 PCY/EP89/01229 Hiure 6 A Flow chart of consa-uctionis showing succesive steps in the deletion of se- quences encoding most of the hypervariable region of the Arabidopsis 2S and their replacement with sequences rich in methionine codons. Step I pmac5-8 pat2s I HindillCip Hiindil pmacat2s 1 Step 2 MuTrAGENESIS (deletion~ RV Acci jiLC) pmacat2s 1c40 I Hindill/Ndel Step 3 pbr322 Hindiltlftdel Step 4 pbrat2s I Complae1enuairy oligo't coding for +NMMMRM MMQPRGDW&,lMMQM~DMOM4J pad 3 pad 4 1NdelmihindI Step 5 pat2s I 320 brp fnrrinent pat2slbg HindIul *pad 7 +i pad 17 1 atilt Step 6 pgscl703a ptad ptad 12 WO 90/04032 WO 9004032PCT/EP89/0 1229 7 /11 Figure 6 B Comparison of the amino acid sequences of the large subunit of several 2S albumins and details of the deletion and substitutions of the hype-vari- able region of the Arabidopsis 2S albumin R. comm. B. excel. B. napus AT2 SI AT2 52 AT2S3 AT2S4 R. comm. B. excel. B. napus AT2 Si AT2S 2 AT2S3 AT2 S4 R. comm. B. excel. B. napus AT2 Si AT2S2 AT2S3 AT2 54 R. commn. B. excel. B. napus AT2Sl AT2S 2 AT2S3 AT2S4 P R RG M P Q G PQ P Q GQ Q P Q G PQ 6 C R C E C RC E L C[V Cj P DICIV C P V C V C P V V P 7CVC P 324 C C E Q C C N Q C C N Q C C S QjCCN K CCS ROQ A E H Q I QQ Q GQ HQ 17= S M C G S RICIN K V CN N VWCD Region of AT2S 1 deleted V RK IY Q TAK 8 R~ F V PF V PF E P F E P F V 6F PS F PS F PP F PP I'PS Amino acid sequence between the 5th and 7th cysteines resulting from the deletion of the HV region ofAT2S I and insertion of an AccI site 6 7 rI7VFCPTLKGI HLPNVCDI Details of the insertions into the AccI site made in examples I and 2. The bases originating from the AccI site are shown in bold print- CT' AT AC CA TA' TG AccI site AAA GGT ATA ATG ATG ATG ATG CCC ATG ATA CAC TTT CCA TAT TAC TAC TAC TAC C-CG TAC TAT GTG Example I AAA CG;T ATA ATG ATG ATG CAA CCA AGG GGC GAT ATG ATG ATG ATA ATG ATG ATG TTT GCA TAT TAC TAC TAC GTT GGT TGG GCG GTA TAC TAC TAC TAT TAC TAC TAC CAA CCA AGG GGC GAT ATG ATG ATG ATA CAC GTT GGT TCC C CTA TAC TAC TAC TAT GTG Exampnle 11 WO 90/04032 i/P9()29 icr/EP89/01229 8/11 Fig-ure 7 Amino acid sequences of the laurge, subunits of the Arabidopsis 2S protein, that remaining after the deletion of most of the hypervariable region. and of the two modified Arabidoosis 2S proteins. AT2Sl Del HV Subst 1 Subst 2 AT2 Si Del HV Subst I Subst 2 AT2S12 Del HV Subst I Subst 2 Q Q Q Q QQ QQ Q QQ Q LK L K G LK G L KG K A V R L QG Q H Q P M Q V R K I Y Q T A K T M QP RGDMMHIMMMQPRGDHMM I I FP S FP S FP S FP S AT2S I unmodified large subunit of AT2S 1 Del 1-W deletion of the AT2S1 I HV region Subst I =substitution by DMMMMRM Subst 2 =substitution by IMMQPRGDMMMUN~IM MQPRGDMMM Number of methionines in the large subunit A12S I Del HV Subst 1 Subst 2 WO 90/04032 PCT/EP89,o 1229 /11 GMAT T CCCOCGGA.TCC GT CGACCTG~CAGCT TGGTCTAGAG GTC WO 90/04032 WO 9004032PCT/EP89/0 1229 10/11 FIGURE 9 CMIR A0 I 8-JAN-87 12:57:02 LEGEND sequence from clone databank sequence from I to 11975 Sites from I to 11975 liaxinme] occurence frequency :2 All enzymes from ENZJB 3- g7 ®RB FIGURE Plant enetic Systemas INTERNATIONAL SEARCH REPORT International A00lication No PCT/EP 89 /01229 1. CLASSIFICATION4 OF SUBJECT MATTER (it several claggirIC3tion symools aooly. indicatll Il A- ccording to inlarr'aztional Patent Ciassiication (IPC) or to both National Classification and IPC 12 N 15/82, C 12 N 15/29, CZ 12 N 5/14, A 01. H 5/00 It. FIELDS SEARCHED Minimum Documentation StarchedT Classification Syitem IClassification Symbols 1PC 5 C 12 N, A 01 H Documention Searched other then Minimum Documentation to the Extent that such Documents areo Included In the Fields Searched a1 Ill. OC1CUMENTS CONSI0ERED TO ME RELEVA~NTO C-agoar;;- Citation of Document, 11 with indication, where stinroprists. of the relevant Passages 'a Relevant to Clism No, 13 X WC, A, 87/07299 (CALGENE) 1-5,7, 3 December 1987 12, 13-21 see page 25, line.24 page 28, line Y 8-11 X Theoretical and Applied Genetics, 157 volume 75, no. 5, 1988, Springer- 12,13-21 Verlag, S.E. Radke et al.: "Transformation of Brassica napus L. using Agrobacterium tuniefaciens: developmentally regulated expression of a reintroduced napin gene", pages 685-694 see the whole article y 8-11 P,X WO, A, 89/03887 *(PLANT GENETIC SYSTEMS) 1-4,6-21 May 1989 see the whole document Special categories of cited i'ncumernts: 10 IT" later document published aler the International filing date document defining the general state at the art which Is not or priority dat and not In conflict with the application but conad~rd t beofpartculr rlevncecited to understand the principle or theory underyirng the Consdere tobe o paticuar etevnceInvention earlier document but publiehed on or sftar the International document al particular relevance: the claimed invention filing date cannot be considered novel ot cannatt be coneidered to "Ll document which may throw doubts on priority claim(s) or Involve an inventive step which Isa cited to establish the pubication date al another document of particular releivance:' the claimed invention citation or other special reason (as specified) cannot be considered to Involve an Inventive step when the document referring to an oral disclosure, use, exhibition or document it combined with one or mote other such dOCu- other means ments, such combination being obvious to a person skiiled document publisired prior to the International filing date but In the art. later than the, priority date claimed document member of the same patent family' IV. CERTIFICATION_____________ Dates of the Actual Completion of the International Search Date of MalIng of this International Search Rsport 6th February 1990 1-22.03, International Searching Authority Signature ol Authorized Oftier EUROPEAN PATENT OFFICE TK. WILLI Form PCTISAt2tO (second sheot) jasnuary 195) Imlrnatonl Atiollcaion No. PCT/EP 89/01229 Ill. DOCUMENTS CONSIDERED TO BE RELEVANT (CONTINUED FROM THE SECOND SHEET) Catgiory Ctation of Oo=ment, wilh )natuCl,1i wrwe acoroozrl.te of t~ reevant oPasages Re(evant to Claim No P,X! EP, A, 0318341 (PLANT GENETIC SYSTEMS) 1-21 31 May 1989 see the whole document Y Plant Molecular Biology, volume 9, 1987, 8,9 Martinus Nijhoff Publi.heu.,, (Dordrecht, NL), M.A. Lawton et al.. "Expression of a soybean f-conclycinin gene under the control of the Cauliflower Mosaic Virus 35S and 19S promoters in transformed petunia tissues", pages 315-324 see the abstract O,Y Journal of Cellular Biochemistry, 1-4,6,7,8, Supplement 11B, UCLA Symposium on 10-17 Plant Gene Systems and their Biology, 16th Annual UCLA Sympsoium Meeting on Molecular and Cellular Biology, Los Angeles, CA, 2-8 February 1987, S.B. Altenbach et al.: "Transfer of a sulfur-rich protein gene from Brazil nuts to other plants", page 46, abstract no. F401 see the abstract A DD, A, 240911 (AKADEMIE DER WISSENSCHAFTEN 1-21 DER DDR) 19 November 1986 see pages A Biotechnology Advances, volume 5, 1987, 1-21 Pergamon Journals Ltd, (GB), J.L. Slightom et al.: "Advances in the molecular biology of plant seed storage proteins", pages 29-45 see page 35, paragraph 2 A Plant Molecular Biology, volume 8, no. 1-21 3, 1987, Martinus Nijhoff Publishers, (Dordrecht, NL), S.B. Altenbach et al.: "Cloning and sequence analysis of a cDNA encoding a Brazil nut protein exceptionally rich in methionine", pages 239-250 see the whole article A Biological Abstracts, volume 86, no. 12, 1-21 1986, (Philadelphia, PA, US), E. Krebbers et al.: "Determination of the processing sites of an arabidopsis 2S albumin and characterization of the complete Form PCT ISA 210 (estra sheo) (Januway 19s) International Atioilcation No. PC-T/EP 89 /01229 F ill OCCUIIINTE CONSIDERED TO 111 RELEVANT (CONTINUED FROM THE SECOND SHEET) C410gory Citationt of Document. with wr-ain *rwr. soofoorat, of It*. r~evant 0assagea Releiivant to Claim No gene family", see pages AB-471-AB-47,2,' abstract 124569, Plant Physiol. (Bethesda) 87(4): 859-866, 1988 A 'Chemical Abstracts. volume lQ8, 1988, 1-21. (Columbus, Ohiri, US), G. Saalbach et al.: "Construction of storage protein genes with increased number of methionine codons and their use in transformation experiments", see page 193, abstract 162663u, 'Biochem. Physiol. Pflanz. 1988, 183(2-3), 217-24 ;UXI Biotechnology, volume 7, September 1989, J. Vandekerckhove et al.: "Enkephalins produced in transgenic plants using modified 2S seed storage proteins", pages 929-932 see paragraph: "Choice of the insertion site" A Eur. J. Biochem., volume 159, 1986, 1-221 FEBS, C.Ampe et al.: "The amino'.rcid sequence of the 2S sulphur-rich proteins from seeds of Brazil nut (Bertholletia excelsa H.B.K.J" pages 597-604 A Journal of Cellular Biochemistry, 8,10,11 Supplement 12C, 1988, UCLA Symposia on Molecular Cellular Biology, Abstracts, 17th Annual Meetings, 28 February 10 April 1988, A.R. Liss, Inc., (New York, US), S.B. Altenbach et al.: "Processing of a Brazil nut sulfur-rich seeis pr~otein in transgenic plants", page 177, abstract L300, see the abstract Form PCT ISA 210 (extra iihaet) (JAkJ" 19#511 ANNEX T(O THE INTERNATIONAL SEARCH REPORT ON INTERNATIONAL PATENT APPLICATION NO. E 8901229 SA 32070 Th! s -nnex lists the patent family members relating to the patent documents cited in the above-mentioned international search report. The members are as contained in the European Patent Office EDP file on 13103/90 The European Patcnt Office is in no way liable for these particulars which are merely given for the purpose of information. Patent document Publk'~tion Pot&.i family Publication cited in search repor datre member(s) date WO-A- 8707299 03-12-87 EP-A- 0270615 15-06-88 JP-T- 1500718 16-03-89 SE-A- 8800i57 19-01-88 WO-A- 8903887 05-05-89 AU-A- 2811889 23-05-89 EP-A- 0319353 07-06-89 EP-A- 0318341 31-05-89 EP-A- 0318341 31-05-89 AU-A- 2811889 23-05-89 WO-A- 8903887 05-05-89 EP-A- 031,9353 07-06-89 00-A- 240911 None M For more details about this annex ',sie Offcial Journal of I/ic European Patent Officc, No. 1218Z
AU44951/89A 1988-10-14 1989-10-13 A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins Ceased AU634987B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
BE88402611 1988-10-14
EP88402611 1988-10-14
EP88402650A EP0318341B1 (en) 1987-10-20 1988-10-20 A process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins in said plants
BE88402650 1988-10-20
CA000581160A CA1337048C (en) 1987-10-20 1988-10-25 Process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants

Publications (2)

Publication Number Publication Date
AU4495189A AU4495189A (en) 1990-05-01
AU634987B2 true AU634987B2 (en) 1993-03-11

Family

ID=27168086

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44951/89A Ceased AU634987B2 (en) 1988-10-14 1989-10-13 A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins

Country Status (4)

Country Link
JP (1) JP2947843B2 (en)
AU (1) AU634987B2 (en)
CA (1) CA2000661C (en)
WO (1) WO1990004032A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20030315A0 (en) * 2003-02-28 2003-02-28 Joseph Atabekov Methods and constructions for increasing the content of selected amino acids in seeds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007299A1 (en) * 1986-05-29 1987-12-03 Calgene, Inc. Transformation and foreign gene expression in brassica species
AU626821B2 (en) * 1987-10-20 1992-08-13 Plant Genetic Systems N.V. A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD240911A1 (en) * 1983-12-31 1986-11-19 Adw Der Ddr Zi Fuer Genetik Un METHOD FOR PRODUCING NUTRITIONALLY HYGIENICALLY IMPROVED PLANT SEA PROTEINS
AU2811889A (en) * 1987-10-20 1989-05-23 Plant Genetic Systems N.V. A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants
EP0318341B1 (en) * 1987-10-20 1996-07-31 Plant Genetic Systems, N.V. A process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins in said plants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007299A1 (en) * 1986-05-29 1987-12-03 Calgene, Inc. Transformation and foreign gene expression in brassica species
AU626821B2 (en) * 1987-10-20 1992-08-13 Plant Genetic Systems N.V. A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants

Also Published As

Publication number Publication date
JPH03502644A (en) 1991-06-20
CA2000661C (en) 1999-04-13
WO1990004032A1 (en) 1990-04-19
CA2000661A1 (en) 1990-04-14
AU4495189A (en) 1990-05-01
JP2947843B2 (en) 1999-09-13

Similar Documents

Publication Publication Date Title
US5589615A (en) Process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins
US5487991A (en) Process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants
JP3232068B2 (en) Method for producing biologically active peptides by expressing a modified storage seed protein gene in transgenic plants
AU678154B2 (en) Oil-body protein cis-elements as regulatory signals
EP0318341B1 (en) A process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins in said plants
CA2006454C (en) Potatoe tuber specific transcriptional regulation
CA2114788C (en) Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants
AU739442B2 (en) An oleosin 5' regulatory region for the modification of plant seed lipid composition
CA2257198C (en) Suppression of specific classes of soybean seed protein genes
Ohtani et al. Normal and lysine-containing zeins are unstable in transgenic tobacco seeds
AU728100B2 (en) Shoot meristem specific promoter sequences
WO1998045461A9 (en) An oleosin 5' regulatory region for the modification of plant seed lipid composition
CA2450000A1 (en) Method of creating plants with reduced level of saturated fatty acid in seed oil
CA2919816C (en) Gene capable of increasing seed protein content and method of use thereof
CA2915846C (en) Gene capable for improving material productivity in seed and method for use thereof
EP0319353B1 (en) A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants
AU634987B2 (en) A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins
EP0723019B1 (en) 5'-flanking region of an Arabidopsis gene coding for a 2S albumin precursor
AU626821B2 (en) A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants
DE3855455T2 (en) Process for the production of transgenic plants with increased nutritional value by expression of modified 2S storage albums in these plants
Thomas Analysis of Two Seed Abundant Clones of Tomato